About
Leadership
Board of Directors
Advisory Board
Strategic Partners
Platform
DELigase
Targeted Protein Modulation
Targeted Protein Degradation
Targeted Protein Elevation
Degrader-Antibody Conjugates
Pipeline
Pipeline
Hematology-Oncology
Immuno-Oncology
Inflammation
Scientific Resources
Posters & Presentations
Publications
Videos
Mechanisms of Action
Clinical Resources
Clinical Trials
Expanded Access Policy
Investors
Overview
News & Events
Financial Information
Stock Information
Corporate Governance
FAQs
Careers & Culture
Job Openings
Contact
Clinical Activity of NX-5948: A First-in-Class BTK Degrader
Presentations
Clinical Activity of NX-5948: A First-in-Class BTK Degrader
MENU
'
About
Leadership
Board of Directors
Advisory Board
Strategic Partners
Platform
DELigase
Targeted Protein Modulation
Targeted Protein Degradation
Targeted Protein Elevation
Degrader-Antibody Conjugates
Pipeline
Pipeline
Hematology-Oncology
Immuno-Oncology
Inflammation
Scientific Resources
Posters & Presentations
Publications
Videos
Mechanisms of Action
Clinical Resources
Clinical Trials
Expanded Access Policy
Investors
Overview
News & Events
Financial Information
Stock Information
Corporate Governance
FAQs
Careers & Culture
Job Openings
Contact
'
'
'